Physicochemical and physiological properties of 5α-cyprinol sulfate, the toxic bile salt of cyprinid fish

  1. A. F. Hofmann 6 ,*
  1. *Division of Gastroenterology, Department of Medicine, University of California, San Diego, CA 92093-0813
  2. Department of Pediatrics, Mount Sinai School of Medicine, New York, NY 10029-0313
  1. 6To whom correspondence should be addressed. e-mail: ahofmann{at}ucsd.edu

Abstract

5α-Cyprinol sulfate was isolated from bile of the Asiatic carp, Cyprinus carpio. 5α-Cyprinol sulfate was surface active and formed micelles; its critical micellization concentration (CMC) in 0.15 M Na+ using the maximum bubble pressure device was 1.5 mM; by dye solubilization, its CMC was ∼4 mM. At concentrations >1 mM, 5α-cyprinol sulfate solubilized monooleylglycerol efficiently (2.1 molecules per mol micellar bile salt). When infused intravenously into the anesthetized rat, 5α-cyprinol sulfate was hemolytic, cholestatic, and toxic. In the isolated rat liver, it underwent little biotransformation and was poorly transported (Tmax 0.5 μmol/min/kg) as compared with taurocholate. 5α-Cyprinol, its bile alcohol moiety, was oxidized to its corresponding C27 bile acid and to allocholic acid (the latter was then conjugated with taurine); these metabolites were efficiently transported. 5α-Cyprinol sulfate inhibited taurocholate uptake in COS-7 cells transfected with rat asbt, the apical bile salt transporter of the ileal enterocyte. 5α-Cyprinol had limited aqueous solubility (0.3 mM) and was poorly absorbed from the perfused rat jejunum or ileum. Sampling of carp intestinal content indicated that 5α-cyprinol sulfate was present at micellar concentrations, and that it did not undergo hydrolysis during intestinal transit.

These studies indicate that 5α-cyprinol sulfate is an excellent digestive detergent and suggest that a micellar phase is present during digestion in cyprinid fish.

Footnotes

  • 1 Present address for T. Goto: Department of Chemistry and Biochemistry, Numazu College of Technology, Numazu, Shizuoka 410-8501, Japan.

  • 2 Present address for F. Holzinger: Department of Surgery, Inselsspital, University of Bern, Switzerland.

  • 3 Present address for C. Cerrè: Bioikos Farma s.r.l, 40122 Bologna, Italy.

  • 4 Present address for H-T. Ton-Nu: La Jolla Pharmaceutical Company, San Diego, CA 92121.

  • 5 Present address for C. D. Schteingart: Ferring Research Institute, San Diego, CA 92121.

  • Published, JLR Papers in Press, June 16, 2003. DOI 10.1194/jlr.M300155-JLR200

  • Received April 14, 2003.
  • Revision received June 4, 2003.
| Table of Contents

This Article

  1. The Journal of Lipid Research, 44, 1643-1651.
  1. All Versions of this Article:
    1. M300155-JLR200v1
    2. 44/9/1643 most recent

Classifications

Article Usage Stats